Topic: Sutent
Another weak quarter for kidney and liver cancer treatment Nexavar prompted a 5% drop in Onyx Pharmaceuticals' (ONXX) shares Thursday and questions about what exactly is driving the disappointing figures.. Just how concerned followers of the US biotech should be remains to ...
Pfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.. Pfizer said patients who were treated with Sutent were not surviving as long as patients who were treated with another drug, Bayer ...
Pfizer Inc. announced today the discontinuation of the SUN 1170 Phase 3 open-label study of Sutent(r) (sunitinib malate) in advanced hepatocellular carcinoma (HCC), or liver cancer. Pfizer remains committed to the development program for sunitinib and is continuing to study its potential ...
Pfizer says Sutent was not working better than Bayer's Nexavar as a treatment for liver cancerPfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.Pfizer said patients who were treated with Sutent ...
From Around the Web
Video Gallery
-
Say NO to SUTENT
This medication is poisonous!! I urge you to read testimonials ...2008-01-07 -
Kidney Cancer: Metastasized to Lung & Sutent
After 7 years, his cancer metastasized to his lungs. His ...2009-06-11 -
Advanced Kidney Cancer: On Sutent
A 53-year-old male has pains in his right shoulder for ...2009-06-23
